Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.
January 1, 2024 Ivers, Jo-Hanna, Tobin, Katy, Harrington, Colm et al.
A survey of 151 psychiatrists in Ireland found that most hold positive views about psilocybin therapy: 81.5% agreed it shows promise for treating psychiatric disorders, 86.8% supported funding research, 86.8% would refer a patient if licensed, and 78.1% would consider it for themselves. However, only 40.0% felt knowledgeable and 9.9% felt adequately prepared to participate in such therapy. A minority expressed concerns about safety (6.6% thought it unsafe under medical supervision), potential addiction (21.9%), and lack of robust evidence. Consultant psychiatrists were less optimistic than trainees about its use for bipolar depression and emotionally unstable personality disorder.